Logan J, Wolf A P, Shiue C Y, Fowler J S
J Neurochem. 1987 Jan;48(1):73-83. doi: 10.1111/j.1471-4159.1987.tb13129.x.
Positron emission tomography (PET) with labeled neuroleptics has made possible the study of neurotransmitter-receptor systems in vivo. In this study we investigate the kinetics of the 3,4-dihydroxyphenylethylamine (dopamine) receptor-ligand binding using PET data from a series of experiments in the baboon with the 18F-labeled drugs spiperone, haloperidol, and benperidol. Models used to describe these systems are based on first-order kinetics which applies at high specific activity (low receptor occupancy). The parameters governing the uptake and loss of drug from the brain were found by fitting PET data from regions with little or no receptor concentration (cerebellum) and from experiments in which specific binding was blocked by pretreatment with the drug (+)-butaclamol. Receptor constants were determined by fitting data from receptor-containing structures. Correcting the arterial plasma activities (the model driving function) for the presence of drug metabolites was found to be important in the modeling of these systems.
用标记抗精神病药物的正电子发射断层扫描(PET)技术使在体研究神经递质-受体系统成为可能。在本研究中,我们利用来自狒狒的一系列实验的PET数据,使用18F标记的药物螺哌隆、氟哌啶醇和苄哌利多,研究3,4-二羟基苯乙胺(多巴胺)受体-配体结合的动力学。用于描述这些系统的模型基于一级动力学,该动力学适用于高比活性(低受体占有率)。通过拟合小脑(几乎没有或没有受体浓度的区域)的PET数据以及用药物(+)-布他拉莫预处理阻断特异性结合的实验数据,确定了控制药物从脑内摄取和丢失的参数。通过拟合来自含受体结构的数据来确定受体常数。发现在这些系统的建模中,校正动脉血浆活性(模型驱动函数)中药物代谢物的存在很重要。